Blinatumomab is an injectable drug that works as an antibody, binding to the membranes of cancer cells and allowing them to be more easily identified by the immune system. Thus, defense cells have an easier time to eliminate cancer cells, especially in the case of acute lymphoblastic leukemia.
This medicine may also be known commercially as Blincyto and should only be used in the hospital for cancer treatment, under the guidance of an oncologist.
Price
This medicine cannot be bought in conventional pharmacies, being used only during the treatment of cancer in the hospital or in specialized centers, such as INCA, for example.
What is it for
Blinatumomab is indicated for the treatment of acute precursor B-cell lymphoblastic leukemia, Philadelphia negative chromosome, in relapse or refractory.
How to use
The dose of blinatumomab to be administered should always be guided by an oncologist, as it varies according to the person's characteristics and the stage of the disease's evolution.
The treatment is done with 2 cycles of 4 weeks each, separated by 2 weeks, and you must be hospitalized during the first 9 days of the first cycle and for 2 days of the second cycle.
Possible side effects
The most common side effects of using this remedy include anemia, excessive tiredness, low blood pressure, insomnia, headache, tremor, dizziness, cough, nausea, vomiting, constipation, abdominal pain, back pain, fever, pain joints, chills and blood test changes.
Who should not use
Blinatumomab is contraindicated for women who are breastfeeding and people with allergies to any of the components of the formula. In addition, in the case of pregnant women, it should only be used with guidance from the obstetrician.
